V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10008913 | 10004919 | 1.66 | 60 | Palliative (P) | 2017-03-30 | 2017-06-08 | Trifluridine + Tipiracil | N | N | 10495054 | CVD |
| 10008914 | 10004919 | 1.72 | 92.4 | Curative (C) | 2017-08-29 | 2017-08-31 | Temozolomide + RT | 02 | N | 10495054 | NIVOLUMAB |
| 10008915 | 10004923 | 1.8 | 74 | Palliative (P) | 2014-11-06 | 2014-11-07 | Cisplatin 100 + RT(H&N) 1 day | N | N | 10496656 | NIVOLUMAB |
| 10008916 | 10004927 | 1.71 | 72.3 | Palliative (P) | 2017-09-06 | 2017-10-23 | Bortezomib + Cyclophos + Pred | 2 | N | 10496956 | ECX |
| 10008917 | 10007482 | null | 69 | Neo-adjuvant (N) | 2017-10-30 | 2018-01-07 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | 10498611 | IMATINIB |
| 10008918 | 10004936 | null | 82 | Palliative (P) | null | 2017-11-20 | Docetaxel + Nintedanib | Y | null | 10501566 | CYTARABINE |
| 10008919 | 10004941 | 1.65 | 76.8 | Palliative (P) | 2018-04-18 | 2018-04-24 | Methotrexate High Dose (3g/m2) | N | N | 10502066 | ECARBOX |
| 10008920 | 10004946 | 1.79 | 76 | Palliative (P) | 2018-02-14 | 2018-03-13 | Enzalutamide | N | N | 10502197 | OXALIPLATIN + RALTITREXED |
| 10008921 | 10004953 | 1.8 | 136.1 | null | 2018-10-08 | 2018-10-09 | Cyclophosphamide High Dose | 2 | Y | 10502964 | IPILIMUMAB |
| 10008922 | 10004959 | 0 | 89.7 | null | 2017-12-11 | 2018-03-15 | OXALIPLATIN | 2 | Y | 10504071 | METHOTREXATE INTRATHECAL |
| 10008923 | 10007495 | 1.74 | 0 | Disease modification (D) | 2015-10-14 | 2015-11-23 | Cisplatin +Fluorouracil (3 wk) | N | N | 10504251 | CISPLATIN + GEMCITABINE |
| 10008924 | 10004967 | 1.78 | 85 | Palliative (P) | 2018-02-21 | 2018-02-21 | Enzalutamide | N | N | 10504393 | CISPLATIN + PEMETREXED |
| 10008925 | 10007500 | 1.66 | 78.5 | Curative (C) | 2017-03-12 | 2017-03-12 | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE | 2 | N | 10505533 | TOPOTECAN |
| 10008926 | 10004977 | 1.84 | 89 | Curative (C) | 2017-08-11 | 2017-08-31 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | N | 10505550 | DA-EPOCH |
| 10008927 | 10004982 | 1.68 | 80.6 | Palliative (P) | 2019-08-30 | 2019-08-30 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 10505847 | MELPHALAN |
| 10008928 | 10004982 | 1.57 | 58.8 | Curative (C) | 2018-09-22 | 2018-09-22 | Trifluridine + Tipiracil | N | N | 10505847 | ERLOTINIB |
| 10008929 | 10004988 | 1.7 | null | Palliative (P) | 2015-11-25 | 2016-11-25 | IMATINIB | 02 | N | 10506788 | CRIZOTINIB |
| 10008930 | 10004995 | 1.5 | 82.3 | Palliative (P) | 2018-06-25 | 2018-06-29 | Chlorambucil | 2 | N | 10507380 | CISPLATIN + VINORELBINE |
| 10008931 | 10005001 | null | 74.05 | Curative (C) | 2018-05-18 | 2018-05-16 | Cisplatin 7 day | 2 | null | 10508636 | CHLORAMBUCIL |
| 10008932 | 10005004 | 1.63 | 60.8 | Adjuvant (A) | 2018-01-31 | 2018-02-01 | VEDex | 02 | N | 10508761 | BORTEZOMIB |
| 10008933 | 10005011 | null | 63.8 | Palliative (P) | 2015-04-13 | 2015-05-25 | Cyclophosphamide + Etoposide (PO) | 02 | N | 10509197 | CISPLATIN + RT |
| 10008934 | 10005014 | 1.73 | 78.3 | Adjuvant (A) | 2016-11-09 | 2016-11-12 | Cetuximab 7 day (>Cycle 2) | 02 | N | 10509678 | OBINUTUZUMAB |
| 10008935 | 10005017 | null | 83.5 | Adjuvant (A) | 2015-10-08 | 2015-11-19 | Brentuximab | 02 | N | 10509722 | DHAP - R |
| 10008936 | 10005025 | 1.69 | 0 | Palliative (P) | 2015-12-02 | 2015-12-02 | Methotrexate intrathecal | Y | N | 10510063 | CETUXIMAB + RT |
| 10008937 | 10005036 | 1.77 | 69.55 | Curative (C) | 2017-08-31 | 2017-09-22 | Trifluridine + Tipiracil | 2 | N | 10511670 | HYDROXYCARBAMIDE |
| 10008938 | 10005041 | 1.76 | 69.4 | Palliative (P) | 2015-01-15 | 2015-01-15 | CABOZANTINIB | 2 | N | 10512345 | DHAP - R |
| 10008939 | 10005044 | 1.7 | 63.9 | Adjuvant (A) | 2016-02-07 | 2016-03-21 | Methotrexate intrathecal | 2 | N | 10512604 | VISMODEGIB |
| 10008940 | 10005052 | 1.81 | 84 | Curative (C) | 2017-10-23 | 2017-10-24 | Panitumumab | N | null | 10514463 | CAPECITABINE + RT |
| 10008941 | 10007534 | null | 84.9 | Palliative (P) | 2016-03-27 | 2018-02-28 | AFATINIB | N | N | 10514513 | FLAG + IDARUBICIN |
| 10008942 | 10005057 | null | 69.5 | Palliative (P) | 2016-07-29 | 2016-08-12 | CYCLOPHOSPHAMIDE + FILGRASTIM | N | N | 10514673 | METHOTREXATE HIGH DOSE |
| 10008943 | 10005061 | null | null | Palliative (P) | 2016-09-05 | 2016-12-25 | Cyclophosphamide oral | 02 | null | 10514873 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 10008944 | 10005065 | 1.85 | 0 | Palliative (P) | 2015-12-12 | 2015-12-22 | Enzalutamide | 2 | null | 10515420 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 10008945 | 10005068 | 1.64 | 93.1 | Neo-adjuvant (N) | 2018-12-26 | 2018-12-26 | PIXANTRONE | 02 | N | 10515574 | NIVOLUMAB |
| 10008946 | 10005078 | null | 88.3 | Adjuvant (A) | 2019-02-17 | 2019-02-17 | Methotrexate intrathecal | N | N | 10517435 | CABOZANTINIB |
| 10008947 | 10005082 | 1.71 | 83.6 | Palliative (P) | 2016-06-25 | 2016-11-13 | Melphalan IV High dose | N | N | 10517595 | BLEOMYCIN |
| 10008948 | 10005086 | 1.7 | null | Adjuvant (A) | 2017-11-07 | 2017-11-11 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB | N | N | 10518314 | GEMTUZUMAB OZOGAMICIN |
| 10008949 | 10005086 | 1.87 | 94.1 | Palliative (P) | 2017-05-11 | 2017-05-14 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 10518314 | ENRICH TRIAL |
| 10008950 | 10005088 | 1.7 | 66.4 | Palliative (P) | 2018-03-31 | 2018-04-22 | Pazopanib | N | N | 10519073 | TRIFLURIDINE + TIPIRACIL |
| 10008951 | 10005090 | 1.82 | null | Curative (C) | null | 2018-05-11 | Melphalan IV High dose | 02 | N | 10519110 | TRIFLURIDINE + TIPIRACIL |
| 10008952 | 10005092 | 1.71 | null | Palliative (P) | 2019-09-29 | 2019-09-29 | Cyclophosphamide oral | N | N | 10519170 | ERLOTINIB |
| 10008953 | 10007553 | null | 58 | Palliative (P) | 2018-07-03 | 2018-07-03 | Gemcitabine + Capecitabine | N | N | 10519214 | CISPLATIN + VINORELBINE |
| 10008954 | 10005106 | 1.61 | 84.9 | Curative (C) | 2017-08-29 | 2017-09-02 | GEM-P | N | N | 10520306 | PALBOCICLIB |
| 10008955 | 10005116 | 1.64 | 80 | Palliative (P) | 2017-07-20 | 2017-09-03 | Cetuximab + FLUOROURACIL + OXALIPLATIN | N | N | 10521975 | FLUOROURACIL + MITOMYCIN + RT |
| 10008956 | 10005117 | 1.7 | 91 | Palliative (P) | 2017-10-18 | 2017-10-24 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 2 | N | 10522682 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 10008957 | 10005122 | 1.77 | null | Disease modification (D) | 2016-02-14 | 2016-03-28 | OSIMERTINIB | 2 | N | 10524321 | CETUXIMAB |
| 10008958 | 10005128 | 1.74 | null | Palliative (P) | 2017-04-11 | 2017-04-14 | CAV | N | N | 10525059 | CISPLATIN + RT |
| 10008959 | 10005129 | 1.7 | 94.9 | Curative (C) | 2018-11-21 | 2018-12-05 | Vincristine (weekly) | N | null | 10525819 | CISPLATIN + GEMCITABINE |
| 10008960 | 10005134 | null | 58 | Adjuvant (A) | 2017-12-27 | 2018-04-12 | CETUXIMAB + IRINOTECAN + MDG | 02 | Y | 10526752 | CHLORAMBUCIL + OBINUTUZUMAB |
| 10008961 | 10005140 | 1.7 | 96 | Palliative (P) | 2017-10-06 | 2017-10-06 | Bendamustine + Obinutuzumab | N | N | 10526987 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 10008962 | 10005143 | 1.71 | 96.2 | Palliative (P) | null | 2016-12-30 | Cisplatin + Radiotherapy | N | N | 10527021 | FLUOROURACIL + MITOMYCIN + RT |